Novo Nordisk Reportedly Plans Early Launch of Wegovy in India Following Lilly's Mounjaro Rollout

Gelonghui April 8 | According to Reuters, following Eli Lilly's launch of its diabetes and obesity drug Mounjaro in India last month, Danish pharmaceutical company Novo Nordisk is considering introducing its popular weight-loss drug Wegovy in India as soon as possible. The report indicates that Novo Nordisk originally planned to launch the drug in 2026 but is now considering starting sales of Wegovy in India this year or within the next few months.